XT
DNTH icon

XTX Topco’s Dianthus Therapeutics DNTH Stock Holding History

XTX Topco’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Sell
13,047
-295
-2% -$17.1K 0.02% 1337
2025
Q4 		$550K Buy
+13,342
New +$517K 0.01% 1508
2025
Q3 		– Sell
-27,003
Closed -$503K – 2715
2025
Q2 		$503K Buy
+27,003
New +$507K 0.02% 1099
2024
Q2 		– Sell
-7,219
Closed -$217K – 1994
2024
Q1 		$217K Buy
+7,219
New +$157K 0.03% 1116
2023
Q3 		– Sell
-1,683
Closed -$20.4K – 1658
2023
Q2 		$20.4K Buy
+1,683
New +$19.1K ﹤0.01% 1319

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco's DNTH Position: Q1 2026 in Review

XTX Topco reduced its Dianthus Therapeutics (DNTH) stake by 2.2% in Q1 2026, selling an estimated $17.1K and leaving 13,047 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #1337.

XTX Topco first reported a position in DNTH in Q2 2023 and has held it in 5 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • XTX Topco held 13,047 shares of Dianthus Therapeutics worth $1.09M as of Q1 2026.
  • XTX Topco sold 295 Dianthus Therapeutics shares in Q1 2026, an estimated $17.1K.
  • Dianthus Therapeutics made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1337 holding.
  • XTX Topco first reported a position in Dianthus Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.